Institutional members access full text with Ovid®

Share this article on:

Two Drugs Now Approved to Treat Pancreatic Cancers

Aschenbrenner, Diane S. MS, RN

AJN The American Journal of Nursing: September 2011 - Volume 111 - Issue 9 - p 23
doi: 10.1097/01.NAJ.0000405056.46195.85
Drug Watch
  • Two kinase inhibitors, sunitnib (Sutent) and everolimus (Afinitor), may now be used to treat pancreatic tumors that can't be removed by surgery or that have spread.

Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch:

© 2011 Lippincott Williams & Wilkins, Inc.